A. Bereket et al., EFFECT OF SHORT-TERM FASTING ON FREE DISSOCIABLE INSULIN-LIKE GROWTH-FACTOR-I CONCENTRATIONS IN NORMAL HUMAN SERUM/, The Journal of clinical endocrinology and metabolism, 81(12), 1996, pp. 4379-4384
A small portion of circulating insulin-like growth factor I (IGF-I) is
detected in the free or readily dissociable state, which is thought t
o be the metabolically active form. The amount of free/dissociable IGF
-I in serum is dependent on a complex interplay between the production
rate and the concentrations of IGF-I and IGF-binding proteins (IGFBPs
). IGF availability is also influenced by posttranslational changes in
IGFBPs that affect the affinity of IGFBPs for IGF-I. In the present s
tudy, we examined whether a short term fast (similar to 12 h) alters t
he serum concentration of free/dissociable IGF-I, and whether these ch
anges are associated with alterations in IGFBP-1 and the proteolysis s
tatus of IGFBP-3. Circulating free/dissociable IGF-I concentrations, a
s assessed by a two-site immunoradiometric assay, did not differ betwe
en fasting and 4 h after a morning meal (1.48 +/- 0.07 vs. 1.50 +/- 0.
07 mu g/L, respectively). Likewise, free/dissociable IGF-I levels meas
ured by RIA after separation by centrifugal ultrafiltration were not d
ifferent between the two groups (1.43 +/- 0.14 vs. 1.38 +/- 0.18 mu g/
L, respectively). IGF-I bioactivity, as measured by thymidine incorpor
ation by fibroblasts, did not differ in fasting and 4-h postprandial s
era. There was no difference In IGFBP-3 and total acid-ethanol-extract
able IGF-I concentrations in serum from fasted and fed subjects. In co
ntrast, the concentration of IGFBP-1 in the serum was increased simila
r to 5-fold in the fasted state compared to fed values. IGFBP-1 existe
d in a highly phosphorylated form under fasting conditions. There was
no change in IGFBP-3 proteolysis assessed either in vivo or in vitro b
etween the fasting and fed states. The results indicate that a physiol
ogically relevant short term overnight fast does not alter the circula
ting levels of free/dissociable IGF-I despite a marked elevation in IG
FBP-1.